Brickell Biotech's Series A Round

Brickell Biotech raised a round of funding on July 12, 2010. Investors include Palisade Capital Management.

Brickell Biotech is a clinical-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of skin diseases. Founded by a team of experie…

Articles about Brickell Biotech's Series A Round: